Search
for
Sort by
Research 121–150 of 967
- Targeting integrin pathways: mechanisms and advances in therapy
- Vitamin D resistance
- A Humanized Mouse Model of Hereditary 1,25-Dihydroxyvitamin D–Resistant Rickets Without Alopecia
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- FASCE, benefit of spironolactone for treating acne of adult female: study protocol for a randomized double-blind trial
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- KCNQ Potassium Channels Modulate Sensitivity of Skin Down-hair (D-hair) Mechanoreceptors
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Metabolic syndrome — a new definition and management guidelines
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Increased plasma renin by vasodilators promotes the progression of abdominal aortic aneurysm
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- The JAK/STAT signaling pathway: from bench to clinic
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Is COVID-19 Gender-sensitive?
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Spironolactone May Reduce the Risk of Incident Rosacea